The increasing costs of Alzheimer's treatment presents a very real threat to both Medicaid and Medicare.
Alzheimer’s is an extremely expensive disease. Medications, repeated doctors visits, hospitalizations, long-term nursing home care – these all
very common with Alzheimer’s patients, and take a financial toll on our health care programs. A total of one out of every five dollars is currently spent by Medicaid and Medicare to treat this horrific disease.
If the current trends continue, it is expected that one out of every three dollars spent by Medicaid and Medicare will go toward treating Alzheimer's, according to FOX News in "Could Alzheimer's really bankrupt Medicare and Medicaid."
With these increasing costs, and increasing cases of Alzheimer’s disease as our population ages, the future of Medicare and Medicaid (Medi-Cal in
California) could be in jeopardy. Under present funding, it is predicted that these programs cannot be sustained due to the demands and costs
associated with Alzheimer’s disease.
What does this mean? Research into preventing and curing the disease is more important than ever. The development of new yet less expensive
treatment methods is also essential. Unfortunately, the Medicare and Medicaid (Medi-Cal) programs were not designed to meet the needs of our increasing elderly population with chronic long-term diseases that require extensive and expensive long-term care and treatment.
Reference: FOX News (March 1, 2017) "Could Alzheimer's really bankrupt
Medicare and Medicaid."